Has Larae Barnes received payments from drug or device companies?

Yes. Drug and device makers reported $2,973 in general payments to Larae Barnes across 132 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Larae Barnes did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Larae Barnes come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Larae Barnes

Family · Tucson, AZNPI 1871834010

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 132 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 11.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $871 and has fallen 67.3% since, to $285 in 2025.

$2,973in general payments, 2019–2025

Across 132 payments — averaging $22.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$347
Jazz Pharmaceuticals Inc.$278
Biohaven Pharmaceutical Holding Company Ltd.$274
Neurocrine Biosciences, Inc.$262
Pfizer$236
Upsher-smith Laboratories LLC$204
plus $1K from 19 others

What the payments were for

Food & beverage$2,973100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	13	$347
Jazz Pharmaceuticals Inc.	9	$278
Biohaven Pharmaceutical Holding Company Ltd.	19	$274
Neurocrine Biosciences, Inc.	8	$262
Pfizer	11	$236
Upsher-smith Laboratories LLC	9	$204
Avanir Pharmaceuticals, Inc.	9	$182
Biohaven Pharmaceuticals, Inc.	9	$124
UCB, Inc.	6	$122
SK Life Science, Inc.	4	$113
Teva Pharmaceuticals USA, Inc.	6	$112
Vanda Pharmaceuticals Inc.	4	$104
Amarin Pharma, Inc.	2	$84
Tanabe Pharma America, Inc.	3	$80
Amgen	3	$72
Axsome Therapeutics, Inc.	3	$63
Neurelis, Inc.	2	$59
Otsuka America Pharmaceutical, Inc.	3	$51
Eisai Inc.	2	$49
Kyowa Kirin, Inc.	2	$33
Argenx US, Inc.	1	$29
Lundbeck LLC	1	$29
Alnylam Pharmaceuticals Inc.	1	$28
Amneal Pharmaceuticals LLC	1	$23
Inspire Medical Systems, Inc.	1	$16

How this compares

$2,973 in reported general payments places this provider in the 85th percentile of 4,119 family providers in Arizona.

See all family providers in Arizona →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Radicava OrsEdaravone	11	$163,104
Aimovig AutoinjectorErenumab-Aooe	18	$13,185
Trazodone Hcl	86	$633

Paid to pharmacies, not to this prescriber.

Other family in Tucson

Lindsay CarterTucson$108K
Vicki McIntyreTucson$68K
Amber KemnitzTucson$33K
Joy BaynesTucson$30K
Cynthia CarstenTucson$27K
Sharon MorganTucson$22K
Margaret SpencerTucson$19K
Polina SamoylovaTucson$18K
Stephanie Niemi-OlsonTucson$15K
Cindy ChangTucson$14K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →